ASC
Ardmore Shipping Corporation
There isn't enough reported data to score ASC yet.
CAT
Caterpillar Inc.
CAT's fundamentals are strong, but it looks expensive: trading at 24x earnings, above its usual 18x. Analysts expect strong earnings growth, though they disagree widely on how much.
ASC Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| Unavailable | |
| Strong |
ASC's profitability and balance sheet are currently strong. There isn't enough data to rate its revenue and cash flow.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
ASC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 3.2x | $8.62 | -55% |
| Forward | 4.5x | $19.02 | — |
| Fair | 6.5x | $17.32 | -8.9% |
| Current | 7.1x | $19.02 | — |
| Expensive | 12x | $31.27 | +64% |
Historical ranges are pointers, not guarantees.
ASC's PE is 7.1x, but its earnings don't support one, so it isn't a reliable read right now.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT has the edge over ASC in the historical PE scenario, which offers more potential upside but is not a forecast.
ASC Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for ASC, with profitability improving. However, they disagree widely on these estimates.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
ASC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.23 | +58% |
| Q3 2026 | $2.67 | +242% |
| Q1 2026 | $1.32 | -42% |
| Q4 2025 | $0.88 | -71% |
| Q3 2025 | $0.78 | -78% |
| Q2 2025 | $1.03 | -70% |
| Q1 2025 | $2.28 | -12% |
| Q4 2024 | $3.06 | +13% |
| Q3 2024 | $3.55 | +0.9% |
ASC has the stronger earnings trend. Trailing diluted EPS is up 159% for ASC versus CAT up 31%.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $29.73 | +17% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT earned $25.48 per share over the past year, up 31% from the year before.
ASC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $203.9M | +151% |
| Q1 2026 | $87.9M | +19% |
| Q4 2025 | $82.9M | +1.1% |
| Q3 2025 | $81.2M | -15% |
| Q2 2025 | $72M | -41% |
| Q1 2025 | $74M | -30% |
| Q4 2024 | $82M | -17% |
| Q3 2024 | $96.1M | +11% |
ASC has the stronger quarterly revenue trend. Revenue is up 183% for ASC versus up 17% for CAT.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 38% | +24 points |
| Q1 2026 | 27% | +18 points |
| Q4 2025 | 15% | +1 points |
| Q3 2025 | 16% | -9.4 points |
| Q2 2025 | 14% | -38 points |
| Q1 2025 | 8.6% | -29 points |
| Q4 2024 | 14% | -14 points |
| Q3 2024 | 25% | +0.8 points |
ASC has the edge over CAT on profitability, with a higher operating margin.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT's revenue has grown year over year for five quarters in a row: $20.7B last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT's operating margin was 20% last quarter, up 3.1 points from the same quarter a year ago.
ASC Free Cash Flow
ASC and CAT do not have enough comparable growth data to identify a winner.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT generated $11.3B in free cash flow over the past year, up 26% from the year before.
ASC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +144K shares |
| 1 year | +0.8% | +312K shares |
| 3 years | -1.7% | -705K shares |
| 5 years | +22% | +7.5M shares |
| Available history | +24% | +7.9M shares |
ASC has 41M diluted shares, up 0.8% from a year ago.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over ASC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
ASC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 1.1x | Healthy |
| Q3 2025 | 1.0x | Very low |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -0.2x | Net Cash |
| Q4 2024 | -0.1x | Net Cash |
| Q3 2024 | -0.1x | Net Cash |
ASC's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has the edge over ASC on leverage, with a lower net debt burden relative to earnings.
ASC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.6 | Neutral |
| Stochastic | 59.3 | Neutral |
ASC's weekly RSI is 55 (neutral) and its Stochastic is 59 (neutral).
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
ASC PE vs Industrials Sector
| Metric | ASC | Sector median | Relative |
|---|---|---|---|
| PE | 7.1x | 24x | 70% below |
| PE % | 56 | 58 | 2 pts below |
ASC has the edge over CAT on valuation relative to its sector.
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.1% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
ASC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $19.1 | 0.4% below |
| 20 week MA | $18.0 | 5.8% above |
| 50 week MA | $16.0 | 19% above |
| 100 week MA | $13.5 | 41% above |
| 200 week MA | $14.5 | 31% above |
ASC has the edge over CAT on trend strength, trading above more of its moving averages.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
ASC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $8.84 | $3.21 | -64% |
| 2021 | $3.21 | $3.51 | +9.3% |
| 2022 | $3.51 | $14.5 | +314% |
| 2023 | $14.5 | $14.1 | -3% |
| 2024 | $14.1 | $12.0 | -15% |
| 2025 | $12.0 | $10.8 | -9.9% |
| 2026 YTD | $10.8 | $19.0 | +76% |
ASC has the edge over CAT on returns for 2026, with the stronger performance.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has finished every year since 2020 higher, and it's up 3.8% so far in 2026.